Target-selective cytosolic delivery of cargo proteins using the VHH-presented OLE-ZIP capsules-Reference-Cited by-同舟云学术

Target-selective cytosolic delivery of cargo proteins using the VHH-presented OLE-ZIP capsules

Published:2024 Issue: Volume: Page:
ISSN:2976-8713
Container-title:RSC Pharmaceutics
language:en
Short-container-title:RSC Pharm.

Author:

Takahashi Kousuke¹,Inoue Yasumichi²,Hida Shigeaki²,Hosoda Ryuki¹,Umezawa Naoki²^ORCID,Akiba Isamu³^ORCID,Umetsu Mitsuo⁴^ORCID,Mizuno Toshihisa¹⁵^ORCID

Affiliation:

1. Department of Life Science and Applied Chemistry, Graduate School of Engineering, Nagoya Institute of Technology, Gokiso-cho, Showa-ku, Nagoya, Aichi 466-8555, Japan

2. Graduate School of Pharmaceutical Sciences, Nagoya City University, 3-1 Tanabe-dori, Mizuho-ku, Nagoya 467-8603, Japan

3. Faculty of Environmental Engineering, the University of Kitakyushu, 1-1 Hibikino, Wakamatsu, Kitakyushu, Fukuoka 808-0135, Japan

4. Department of Biomolecular Engineering, Graduate School of Engineering, Tohoku University, Sendai, Miyagi 980-8579, Japan

5. Department of Nanopharmaceutical Sciences, Graduate School of Engineering, Nagoya Institute of Technology, Gokiso-cho Showa-ku, Nagoya, Aichi 466-8555, Japan

Abstract

In the pursuit of a new generation of protein pharmaceuticals, the efficient delivery of these therapeutics into cells stands out as a crucial challenge.

Funder

Iketani Science and Technology Foundation

Izumi Science and Technology Foundation

Publisher

Royal Society of Chemistry (RSC)

Link

http://pubs.rsc.org/en/content/articlepdf/2024/PM/D4PM00069B

Reference43 articles.

1. Progress in biopharmaceutical development

2. The chemical evolution of oligonucleotide therapies of clinical utility

3. Intracellular Delivery by Membrane Disruption: Mechanisms, Strategies, and Concepts

4. Therapeutic antibodies: successes, limitations and hopes for the future

5. Stability of IgG isotypes in serum